Lost tons of density but hairline has been the same for 2.5 years since I started fin/min/dut
    Finasteride/Dutasteride 4/7/2025

    From the encyclopedia
    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    Dutasteride →

    5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg daily October 2022 - October 2024
    💧 Minoxidil (topical) October 2022 - present
    💊 Dutasteride (oral) 0.5mg 3x weekly January 2024 - October 2024
    💊 Dutasteride (oral) 2.5mg daily December 2024 - present
    💧 RU58841 (topical) 20mg April 2024 - February 2025
    the tone is 😞 negative with no growth results.

    Other terms

    The user experienced worsening hair density despite using finasteride, minoxidil, dutasteride, and RU58841, with some temporary improvement after stopping RU58841. Currently, they are on 2.5mg dutasteride daily and topical minoxidil, but continue to struggle with hair density issues.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research CLINICAL UPDATES IN HAIR

      19 citations , January 1997 in “Dermatologic Clinics”
      This chapter reviews various antiandrogens and androgen inhibitors, detailing their mechanisms, uses, and side effects, with a focus on spironolactone, finasteride, dutasteride, and oral contraceptives.

      research Тіе Modern treatment of androgenetic alopecia

      February 2017 in “Vestnik dermatologii i venerologii”
      This review examines the molecular mechanisms and current treatment options for androgenetic alopecia, highlighting potential future therapies but providing no new experimental findings.

      research Therapeutic strategies for treating hair loss

      42 citations , March 2006 in “Drug Discovery Today: Therapeutic Strategies”
      This article discusses the need for rational strategies in developing hair loss drugs targeting specific events in hair follicle cycling, reporting no clinical findings but emphasizing the importance of understanding molecular controls.

      research Hair growth and rejuvenation: An overview

      81 citations , June 2010 in “Journal of Dermatological Treatment”
      This review discusses recent advancements in hair rejuvenation strategies and assesses the potential of herbal drugs as safer alternatives, but reports no new clinical results.